Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news



Selenium may prevent female bladder cancer: Study

By Stephen Daniells , 08-Dec-2008
Last updated on 08-Dec-2008 at 15:37 GMT2008-12-08T15:37:39Z

Increased levels of selenium may reduce a woman’s risk of bladder cancer by 34 per cent, according to a new study from the US.

Researchers from Dartmouth Medical School also report significant risk reductions for moderate smokers and people with a cancer related to a specific gene – p53.

Other studies have already reported similar association between selenium and bladder cancer among women, but the new results, published in the December issue of Cancer Prevention Research, are said to be the first to show an association between selenium and p53 positive bladder cancer.

"Ultimately, if it is true that selenium can prevent a certain subset of individuals, like women, from developing bladder cancer, or prevent certain types of tumours, such as those evolving through the p53 pathway, from developing, it gives us clues about how the tumours could be prevented in the future and potentially lead to chemopreventive efforts," said lead researcher Margaret Karagas.

Selenium levels have been falling in Europe since the EU imposed levies on wheat imports from the US, where soil selenium levels are high.

As a result, average intake of selenium in the UK has fallen from 60 to 34 micrograms per day, leading to calls from some to enrich soil and fertilizers with selenium to boost public consumption. Selenium-enriched fertilizers are used in Finland.

The European recommended daily intake (RDI) is 65 micrograms. The recommended EC Tolerable Upper Intake Level for selenium is 300 micrograms per day.

Study details

Karagas and her co-workers measured selenium levels in the toenails of 767 people newly diagnosed with bladder cancer (76 per cent male, average age 62) and 1,108 people from the general population (61 per cent male, average ag 61). While no associations were found between selenium levels and bladder cancer risk for the whole population group, significant reductions in risk were found for women (34 per cent), moderate smokers (39 per cent) and those with p53 positive cancer (43 per cent).

"There are different pathways by which bladder cancer evolves and it is thought that one of the major pathways involves alterations in the p53 gene," said Karagas. "Bladder cancers stemming from these alternations are associated with more advanced disease."

The researchers noted that they hope to replicate these findings on a larger scale in order to examine the connection between selenium and bladder cancer in women and those with p53 tumours, as well as with patient prognosis.

Bladders: Maybe. Prostates: Maybe not

In a new study, published in the new issue of the American Journal of Clinical Nutrition, data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study indicates that blood levels of selenium may not impact on the risk of prostate cancer.

The researchers, led by Naomi Allen from the University of Oxford, performed a nested case-control study with 959 men with incident prostate cancer and 1,059 healthy men who acted as the controls for comparison.

The concentration of selenium in the blood was not associated with the risk of developing prostate cancer. These null associations were also observed when the researchers accounted for the stage or grade of disease, and for the smoking status of the disease.

“Plasma selenium concentration was not associated with prostate cancer risk in this large cohort of European men,” concluded Allen and her co-workers.

Sources: Cancer Prevention ResearchDecember 2008, doi:10.1158/1940-6207.CAPR-08-0046"Selenium and Risk of Bladder Cancer: A Population-Based Case-Control Study"Authors: K. Wallace, K.T. Kelsey, A. Schned, J.S. Morris, A.S. Andrew, M.R. Karagas

American Journal of Clinical NutritionDecember 2008, Volume 88, Pages 1567-1575“Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)”Authors: N.E. Allen, P.N. Appleby, A.W. Roddam, A. Tjonneland et al.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars